Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more
Coloplast A/S (CLPBF) - Total Assets
Latest total assets as of December 2025: $48.80 Billion USD
Based on the latest financial reports, Coloplast A/S (CLPBF) holds total assets worth $48.80 Billion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Coloplast A/S - Total Assets Trend (2002–2025)
This chart illustrates how Coloplast A/S’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Coloplast A/S - Asset Composition Analysis
Current Asset Composition (September 2025)
Coloplast A/S's total assets of $48.80 Billion consist of 21.6% current assets and 78.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.0% |
| Accounts Receivable | $5.17 Billion | 10.7% |
| Inventory | $3.91 Billion | 8.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $10.46 Billion | 21.7% |
| Goodwill | $19.29 Billion | 40.0% |
Asset Composition Trend (2002–2025)
This chart illustrates how Coloplast A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Coloplast A/S's current assets represent 21.6% of total assets in 2025, a decrease from 58.1% in 2002.
- Cash Position: Cash and equivalents constituted 2.0% of total assets in 2025, down from 7.1% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 40.0% of total assets.
Coloplast A/S Competitors by Total Assets
Key competitors of Coloplast A/S based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Coloplast A/S - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Coloplast A/S generates 0.58x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Coloplast A/S generates $7.52 in net profit.
Coloplast A/S - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.30 | 0.81 | 0.98 |
| Quick Ratio | 0.81 | 0.52 | 0.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.37 Billion | $ -2.40 Billion | $ -115.00 Million |
Coloplast A/S - Advanced Valuation Insights
This section examines the relationship between Coloplast A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.78 |
| Latest Market Cap to Assets Ratio | 0.30 |
| Asset Growth Rate (YoY) | 0.4% |
| Total Assets | $48.27 Billion |
| Market Capitalization | $14.28 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Coloplast A/S's assets below their book value (0.30 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Coloplast A/S's assets grew by 0.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Coloplast A/S (2002–2025)
The table below shows the annual total assets of Coloplast A/S from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $48.27 Billion | +0.42% |
| 2024-09-30 | $48.07 Billion | -0.18% |
| 2023-09-30 | $48.16 Billion | +37.77% |
| 2022-09-30 | $34.96 Billion | +120.67% |
| 2021-09-30 | $15.84 Billion | +17.35% |
| 2020-09-30 | $13.50 Billion | +6.02% |
| 2019-09-30 | $12.73 Billion | +8.18% |
| 2018-09-30 | $11.77 Billion | -2.33% |
| 2017-09-30 | $12.05 Billion | +9.48% |
| 2016-09-30 | $11.01 Billion | +1.76% |
| 2015-09-30 | $10.82 Billion | +4.22% |
| 2014-09-30 | $10.38 Billion | +10.84% |
| 2013-09-30 | $9.36 Billion | -7.98% |
| 2012-09-30 | $10.18 Billion | +10.39% |
| 2011-09-30 | $9.22 Billion | +18.62% |
| 2010-09-30 | $7.77 Billion | -2.41% |
| 2009-09-30 | $7.96 Billion | -0.23% |
| 2008-09-30 | $7.98 Billion | +2.98% |
| 2007-09-30 | $7.75 Billion | -2.91% |
| 2006-09-30 | $7.98 Billion | +34.95% |
| 2005-09-30 | $5.92 Billion | +4.86% |
| 2004-09-30 | $5.64 Billion | +5.24% |
| 2003-09-30 | $5.36 Billion | +19.40% |
| 2002-09-30 | $4.49 Billion | -- |